Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial - The Lancet
Dermatologic Therapy: Vol 33, No 3
TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis | Nature Communications
Adalimumab for Refractory Folliculitis Decalvans. — Donovan Hair Clinic
Full article: Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel disease
Clinical findings of the patient. (A) Erythematous scaly papules and... | Download Scientific Diagram
Potential predictive biomarkers of adalimumab response in patients with hidradenitis suppurativa* - Cao - 2021 - British Journal of Dermatology - Wiley Online Library
Chronic verrucous sarcoidosis associated with human papillomavirus infection: Improvement with adalimumab | Semantic Scholar
A prospective, longitudinal monocentric study on laser Doppler imaging of microcirculation: comparison with macrovascular pathophysiology and effect of adalimumab treatment in early rheumatoid arthritis | SpringerLink
ESPRIT: 10-year post-marketing surveillance registry of adalimumab for moderate to severe psoriasis: All treatment-emergent mali
Extensive Nevus Comedonicus with Inflammatory Nodules and Cysts Controlled with Adalimumab
AbbVie Announces Global Resolution of HUMIRA® (adalimumab) Patent Disputes with Amgen Allowing Commercialization Of AMGEVITA™ - iData Research
Overview of Humira® Biosimilars: Current European Landscape and Future Implications - Journal of Pharmaceutical Sciences
Treatment of Hidradenitis Suppurativa in 2021 & Beyond - Next Steps in Dermatology
Adalimumab Effective in Pediatric Plaque Psoriasis | RheumNow
PHARMACY POLICY STATEMENT
Protect at all costs: How the maker of the world's bestselling drug keeps prices sky-high | Fortune
Early administration of adalimumab for paediatric uveitis due to Behçet's disease | Pediatric Rheumatology | Full Text
AbbVie, Johnson & Johnson Lead US Immunology Drug Market Due to High Cost of Biologic Treatments - iData Research
View Image
Guselkumab Effective for Treatment of Moderate-to-Severe Plaque Psoriasis
The best combination for the treatment of Hidradenitis Suppurativa - Dr. Anuj Pall MD, PhD - YouTube
Treatment of Recalcitrant Generalized Granuloma Annulare With Adalimumab - JDDonline - Journal of Drugs in Dermatology
Early administration of adalimumab for paediatric uveitis due to Behçet's disease | Pediatric Rheumatology | Full Text
Phototherapy remains a valuable psoriasis treatment
Excimer Laser Therapy for Hairline Psoriasis: A Useful Addition to the Scalp Psoriasis Treatment Algorithm
Refractory dissecting Cellulitis of the Scalp Successfully controlled with Adalimumab. | Semantic Scholar
